Loading candles…
Caplin Point Laboratories Ltd, incorporated in 1990, is an Indian pharmaceutical company operating primarily through a 100% export-oriented business model. The company engages in manufacturing and sourcing active pharmaceutical ingredients (APIs), finished pharmaceutical formulations including ointments and creams, as well as research and development and clinical research. It owns distribution networks and focuses on serving markets in Latin America, Francophone Africa, the USA, Canada, Australia, Mexico, Brazil, and other countries. Caplin Point has a dominant presence in Latin America and Francophone Africa and is expanding its footprint in regulated markets such as the USA, Canada, Australia, Mexico, and Brazil. Its approach combines ownership of distribution networks with targeting the Bottom of the Pyramid market segment within the pharmaceutical industry.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and declaration of dividend, if any. | 14 May 2026 |
| Unaudited Results - FY25 | To consider and approve the unaudited financial results for the period ended December 31, 2025 | 5 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 5 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 and dividend | 7 Aug 2025 |
| Audited Results - FY25 | To consider and approve the annual audited financial results of the company for the period ended March 31, 2025 and declaration of interim dividend. | 15 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.